Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma
Clinical trial NCT03466827 · UNKNOWN
Trial details
- NCT number
- NCT03466827
- Sponsor
- Morten Mau-Soerensen
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-12
- Primary completion
- 2020-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.